BAM
SEEL

Belpointe Asset Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Belpointe Asset Management’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13
Closed -$34.6K – 3545
2023
Q1 		$34.6K Hold
13
– – ﹤0.01% 1953
2022
Q4 		$34K Buy
+13
New +$34K ﹤0.01% 1838